Optomed Oyj Statistics

Total Valuation

Optomed Oyj has a market cap or net worth of EUR 75.98 million. The enterprise value is 69.32 million.

Market Cap	75.98M
Enterprise Value	69.32M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Optomed Oyj has 19.66 million shares outstanding. The number of shares has increased by 11.78% in one year.

Current Share Class	n/a
Shares Outstanding	19.66M
Shares Change (YoY)	+11.78%
Shares Change (QoQ)	+2.58%
Owned by Insiders (%)	0.65%
Owned by Institutions (%)	39.85%
Float	19.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.80
PB Ratio	3.21
P/TBV Ratio	4.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.72
EV / Sales	4.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.05

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.16.

Current Ratio	2.81
Quick Ratio	2.33
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-2.04
Interest Coverage	-36.97

Financial Efficiency

Return on equity (ROE) is -24.77% and return on invested capital (ROIC) is -13.69%.

Return on Equity (ROE)	-24.77%
Return on Assets (ROA)	-11.84%
Return on Invested Capital (ROIC)	-13.69%
Return on Capital Employed (ROCE)	-22.01%
Revenue Per Employee	130,870
Profits Per Employee	-47,391
Employee Count	115
Asset Turnover	0.49
Inventory Turnover	2.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.92% in the last 52 weeks. The beta is 2.24, so Optomed Oyj's price volatility has been higher than the market average.

Beta (5Y)	2.24
52-Week Price Change	-3.92%
50-Day Moving Average	4.10
200-Day Moving Average	4.70
Relative Strength Index (RSI)	46.26
Average Volume (20 Days)	40,011

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optomed Oyj had revenue of EUR 15.05 million and -5.45 million in losses. Loss per share was -0.29.

Revenue	15.05M
Gross Profit	9.68M
Operating Income	-5.77M
Pretax Income	-5.52M
Net Income	-5.45M
EBITDA	-5.10M
EBIT	-5.77M
Loss Per Share	-0.29

Full Income Statement

Balance Sheet

The company has 10.47 million in cash and 3.81 million in debt, giving a net cash position of 6.66 million or 0.34 per share.

Cash & Cash Equivalents	10.47M
Total Debt	3.81M
Net Cash	6.66M
Net Cash Per Share	0.34
Equity (Book Value)	23.64M
Book Value Per Share	1.20
Working Capital	10.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.60 million and capital expenditures -275,000, giving a free cash flow of -1.87 million.

Operating Cash Flow	-1.60M
Capital Expenditures	-275,000
Free Cash Flow	-1.87M
FCF Per Share	-0.10

Full Cash Flow Statement

Margins

Gross margin is 64.29%, with operating and profit margins of -38.32% and -36.21%.

Gross Margin	64.29%
Operating Margin	-38.32%
Pretax Margin	-36.65%
Profit Margin	-36.21%
EBITDA Margin	-33.85%
EBIT Margin	-38.32%
FCF Margin	n/a

Dividends & Yields

Optomed Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.78%
Shareholder Yield	-11.78%
Earnings Yield	-7.17%
FCF Yield	-2.46%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optomed Oyj has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a